ANAYANCY DRISCOLL LUNA: Open Payments
NPI 1831591064 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 14 payments from 7 companies in 2025. Trend: 2023 $786 · 2024 $361 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $184 |
| PFIZER INC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Phadia US Inc. | 1 | $29 |
| Novo Nordisk Inc | 2 | $29 |
| Amgen Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $16 |
Products named: MOUNJARO, PAXLOVID, AIRSUPRA, ImmunoCAP, OTEZLA, FREESTYLE LIBRE 3, Ozempic, Wegovy.
Industry payments across TX — which companies pay providers there.
